All In Biotech

Free tool

FAERS Monitor: Basaglar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 205692 or its brand name (Basaglar, Insulin Glargine). Reports on generic versions are filed under their own applications.

Reports

45,246

Serious

26,158

58% of reports

Hospitalization

14,746

Death reported

3,004

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased7,220
  • incorrect dose administered2,585
  • drug ineffective2,134
  • visual impairment2,008
  • hypoglycaemia1,944
  • blood glucose decreased1,684
  • nausea1,591
  • accidental underdose1,544
  • diarrhoea1,438
  • injection site pain1,423
  • fatigue1,345
  • inappropriate schedule of product administration1,306
  • dyspnoea1,288
  • off label use1,252
  • vomiting1,234

Reports by year received

View as table
YearReports
200499
2005108
200689
2007111
2008169
2009191
2010299
2011360
2012264
2013403
2014423
2015619
2016740
20172,296
20184,877
20195,649
20204,766
20214,528
20224,659
20233,922
20244,035
20253,981
20262,657

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,008,913 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
accidental underdoseSignal1,54455.752.974,096
hypoglycaemiaSignal1,94419.418.532,563
blood glucose increasedSignal7,22018.518.1115,848
blood glucose decreasedSignal1,68416.916.124,280
visual impairmentSignal2,0087.67.311,461
incorrect dose administeredSignal2,5855.35.19,042
inappropriate schedule of product administrationSignal1,3063.43.22,196
injection site painSignal1,4232.22.1896
vomiting1,2341.21.250
dyspnoea1,2881.11.04
diarrhoea1,4381.01.02
nausea1,5910.90.98
fatigue1,3450.80.867
drug ineffective2,1340.80.7185
off label use1,2520.70.6221

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.